Skip to main content
Log in

Variation of antibiotic consumption and its correlated factors in Turkey

  • Pharmacoepidemiology and Prescription
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Background

Presentation of antibiotic utilization data by reliable and comparable analyses constitutes an important way of ensuring rational use of antibiotics. This study aimed to evaluate antibiotic consumption (AC) of Turkey by each city/region and to investigate any association of such consumption with socio-economic factors.

Method

For 81 provinces and 12 regions in Turkey, AC data from IMS (Intercontinental Medical Statistics) in 2011 was analyzed in accordance with “ATC/DDD, DID” (Anatomical Therapeutic Chemical/Defined Daily Doses, DID = DDD/1000 inhabitants/day) methodology supported by World Health Organization. Association between provincial AC rates and socio-economic development index (SEDI)-2011 and between regional AC rates and some health indicators were analyzed.

Results

While provincial AC data of Turkey was detected to vary between 17.2 and 55.2 DID (Hakkari and Usak, respectively), regional AC ranged from 28.4 to 48.9 DID (Middle Eastern Anatolia and Western Anatolia, respectively). Mostly consumed antibiotic group among all regions were beta-lactamase inhibitor/penicillin combinations (range: 9.9–17.6 DID). SEDI and AC of each city showed positive correlation (rho = 0.683, p < 0.001). While regional AC was positively associated with percentage of 14-year-old population (p = 0.002) and pharmacist density (p < 0.001), it was negatively associated with physician density (p = 0.038).

Conclusion

It is remarkable that Turkey, at both provincial and regional levels, exhibits important variations in AC, which is proportional to socio-economic status. Besides, the consumption is found to be closely associated with recognized critical factors of access to healthcare. These findings are expected to provide important insights to the activities promoting rational use of antibiotics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Holloway KA, van Dijk L, World Health Organization (2011) The world medicines situation, third edition. WHOb/EMP/MIE/2011.2.2. World Health Organization, Geneva

    Google Scholar 

  2. ECDC/EMEA. Technical Report. The bacterial challenge: time to react. Sept 2009. http://www.ecdc.europa.eu/en/publications/Publications/0909TER_The_Bacterial_Challenge_Time_to_React.pdf (accessed at December 27, 2016)

  3. US Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. April 2013. http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf (accessed at December 27, 2016)

  4. Hosoglu S, Karabay O (2013) Healthcare expenditures and increasing antimicrobial consumption in Turkey. J Chemother 25(1):63

    Article  Google Scholar 

  5. Global Action Plan on Antimicrobial Resistance. World Health Organization. 2015, ISBN 978 92 4 150976 3

  6. Masiero G, Filippini M, Ferech M, Goossens H (2010) Socioeconomic determinants of outpatient antibiotic use in Europe. Int J Public Health 55(5):469–478

    Article  PubMed  PubMed Central  Google Scholar 

  7. Bronzwaer SL, Cars O, Büchholz U, Molstad S, Goettsch W, Veldhuijzen IK, Kool JL, Sprenger MJ, Degener JE, European Antimicrobial Resistance Surveillance System (2002) A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 3:278–282

    Article  Google Scholar 

  8. Aabenhus R, Siersma V, Hansen MP, Bjerrum L (2016) Antibiotic prescribing in Danish general practice 2004–13. J Antimicrob Chemother. doi:10.1093/jac/dkw117

    PubMed  Google Scholar 

  9. Versporten A, Bolokhovets G, Ghazaryan L, Abilova V, Pyshnik G, Spasojevic T, Korinteli I, Raka L, Kambaralieva B, Cizmovic L, Carp A, Radonjic V, Maqsudova N, Celik HD, Payerl-Pal M, Pedersen HB, Sautenkova N, Goossens H, WHO/Europe-ESAC Project Group (2014) Antibiotic use in eastern Europe: a cross-national database study in coordination with the WHO regional Office for Europe. Lancet Infect Dis 14(5):381–387

    Article  PubMed  Google Scholar 

  10. Elseviers MM, Ferech M, Vander Stichele RH, Goossens H (2007) Antibiotic use in ambulatory care in Europe (ESAC data 1997–2002): trends, regional differences and seasonal fluctuations. Pharmacoepidemiol Drug Saf 16(1):115–123

    Article  PubMed  Google Scholar 

  11. Matuz M, Benko R, Doro P, Hajdu E, Nagy G, Nagy E, Monnet DL, Soos G (2006) Regional variations in community consumption of antibiotics in Hungary, 1996–2003. Br J Clin Pharmacol 61:96–100

    Article  PubMed  PubMed Central  Google Scholar 

  12. T.C. Sağlık Bakanlığı Refik Saydam Hıfzıssıhha Merkezi Başkanlığı, Hıfzıssıhha Mektebi Müdürlüğü. Hekimlerin Akılcı İlaç Kullanımına Bakışı [Physicians’ Perspective of Rational Drug Use]. Akdag R (Ed.), Araştırma serisi: 10, Ankara 2011. Sağlık Bakanlığı Yayın No: 857. ISBN: 978–975–590-396-5

  13. T.C. Sağlık Bakanlığı Refik Saydam Hıfzıssıhha Merkezi Başkanlığı, Hıfzıssıhha Mektebi Müdürlüğü. Birinci Basamakta Akılcı Reçete Yazımı [Writing Rational Prescriptions in Primary Health Care Centers]. Akdag R (Ed.), Araştırma serisi: 7, Ankara 2011. Sağlık Bakanlığı Yayın No: 854. ISBN: 978–975–590-400-9

  14. Mollahaliloglu S, Alkan A, Donertas B, Ozgulcu S, Akici A (2011) Assessment of the prescriptions written in different provinces of Turkey in terms of drug utilization principles. Marmara Med J 24:162–173

    Google Scholar 

  15. T.C. Sağlık Bakanlığı Refik Saydam Hıfzıssıhha Merkezi Başkanlığı, Hıfzıssıhha Mektebi Müdürlüğü. Toplumun Akılcı İlaç Kullanımına Bakışı [Community Perspective of Rational Drug Use]. Akdag R (Ed.), Araştırma serisi: 9, Ankara 2011. Sağlık Bakanlığı Yayın No: 856. ISBN: 978–975–590-394-1

  16. Ministry of Health (Turkey) (2012) Turkey health statistics yearbook 2011. Ministry of Health (Turkey), Ankara, Turkey

    Google Scholar 

  17. World Bank national accounts data, and OECD National Accounts data files. GDP per capita http://data.worldbank.org/indicator/NY.GDP.PCAP.CD?end=2011&locations=TR-1W&start=2011&view=bar (accessed at December 27, 2016)

  18. Quintiles IMS Turkey web site. Available at http://www.imshealth.com/tr_TR (accessed at December 27, 2016)

  19. WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment 2015. Oslo, 2015

  20. Ulusal Antibakteriyel İlaç Sürveyansı – 2011, National Antibacterial Drug Surveillance – 2011 Turkish Ministry of Health Publication No: 995, Ankara, 2015

  21. T.C. Kalkınma Bakanlığı. İllerin ve Bölgelerin Sosyo-Ekonomik Gelişmişlik Sıralaması Araştırması (SEGE-2011) [Ministry of Development (Turkey), Survey of Socio-Economic Development Ranking of Provinces and Regions], Ankara 2013

  22. European Centre for Disease Prevention and Control (2014) Surveillance of antimicrobial consumption in Europe 2012. ECDC, Stockholm

    Google Scholar 

  23. Goossens H, Ferech M, Vander Stichele R, Elseviers M, ESAC Project Group (2005) Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365:579–587

    Article  PubMed  Google Scholar 

  24. SWEDRES (2006) A report on Swedish antibiotic utilisation and antibiotics in human medicine (2006) The Swedish Strategic Programme against Antibiotic Resistance and the Swedish Institute for Infectious Disease Control, ISSN 1400–3473

  25. Kern W, Nink K, Steib-Bauert M, Schröder H (2006) Regional variation in outpatient antibiotic prescribing in Germany. Infection 34(5):269–273

    Article  CAS  PubMed  Google Scholar 

  26. Boccia D, Alegiani SS, Pantosti A, Moro ML, Traversa G (2004) The geographic relationship between the use of antimicrobial drugs and the pattern of resistance for Streptococcus pneumoniae in Italy. Eur J Clin Pharmacol 60(2):115–119

    Article  CAS  PubMed  Google Scholar 

  27. Patz JA, Githeko AK, McCarty JP, Hussein S, Confalonieri U (2008) Climate change and infectious diseases. Infect Dis 9(6):103–132

    Google Scholar 

  28. Sensoy, S. (2004) The mountains influence on Turkey climate. In: Balwois Conference on Water Observation and Information System for Decision Support

  29. Božić B, Bajčetić M (2016) Seasonal variations in antibiotic consumption in paediatric primary care settings in Serbia. Arch Dis Child 101:e1. doi:10.1136/archdischild-2015-310148.57

    Google Scholar 

  30. Suda KJ, Hicks LA, Roberts RM, Hunkler RJ, Taylor TH (2014) Trends and seasonal variation in outpatient antibiotic prescription rates in the United States, 2006 to 2010. Antimicrob Agents Chemother 58(5):2763–2766

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Kemper KJ, APA Standing Committee on Public Policy and Advocacy (2002) APA policy on clinical and environmental factors contributing to antibiotic resistant bacteria. Ambul Pediatr 2(3):230–233

    Article  PubMed  Google Scholar 

  32. Akici A, Kalaca S, Ugurlu MU, Oktay S (2004) Prescribing habits of general practitioners in the treatment of childhood respiratory-tract infections. Eur J Clin Pharmacol 60(3):211–216

    Article  PubMed  Google Scholar 

  33. Bozic B, Bajcetic M (2015) Use of antibiotics in paediatric primary care settings in Serbia. Arch Dis Child 100(10):966–969

    Article  PubMed  Google Scholar 

  34. Turkish Statistics Institution. Median Age by provinces and sex. Available at: http://www.turkstat.gov.tr/PreIstatistikTablo.do?istab_id=2306. (accessed at December 27, 2016)

  35. Augustin J, Mangiapane S, Kern WV (2015) A regional analysis of outpatient antibiotic prescribing in Germany in 2010. Eur J Pub Health 25(3):397–399

    Article  Google Scholar 

  36. World Health Organization (2014) The role of pharmacist in encouraging prudent use of antibiotics and averting antimicrobial resistance: a review of policy and experience in Europe. WHO Regional Office for Europe, Copenhagen

    Google Scholar 

  37. Llor C, Cots JM (2009) The sale of antibiotics without prescription in pharmacies in Catalonia, Spain. Clin Infect Dis 48(10):1345–1349

    Article  PubMed  Google Scholar 

  38. Morgan DJ, Okeke IN, Laxminarayan R, Perencevich EN, Weisenberg S (2011) Non-prescription antimicrobial use worldwide: a systematic review. Lancet Infect Dis 11:692–701

    Article  PubMed  PubMed Central  Google Scholar 

  39. Ministry of Health Turkish Medicines and Medical Devices Agency. Rational Drug Use National Action Plan 2014–2017. Available from http://www.akilciilac.gov.tr/wp-content/uploads/2014/11/Rational-Drug-Use-National-Action-Plan.pdf (accessed at December 27, 2016)

  40. Niederman MS (2005) Principles of appropriate antibiotic use. Int J Antimicrob Agents 26(SUPPL. 3):170–175

    Article  Google Scholar 

  41. Gok H, Akıcı A, Dogukan MN, Dogru ST, Dizici M, Yer M, Mirahmetoglu O (2013) Survey on medicine storage and usage habits of households in Turkey. 7. International, Conference on Quality in Health Care, Accreditation and Patient Safety.(QPS-2013), Antalya, Turkey. 10–13 April 2013. P6.1

Download references

Acknowledgements

The authors thank Dr. H. Goossens, Dr. A. Versporten, and M.Sc. Pharm. H.B. Pedersen for their assistance in validation of antibiotic consumption and Dr. H. Gursoz and respective staff/consultants of Turkish Medicines and Medical Devices Agency for their assistance in data collection and calculation of antibiotic consumption.

Authors’ contributions

Ahmet Akici (AhA) and AS planned and designed the study. AhA, VA, and AS performed all data analysis. AS, BM, and MA calculated data for antibiotic consumption. AS, AhA, VA, BM, MA, and Ali Alkan (AlA) were involved in the interpretation of the data. AS, AhA, and VA prepared the manuscript. All authors reviewed the manuscript and approved for publication.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ahmet Akici.

Ethics declarations

Funding

This research did not receive any specific grant.

Conflict of interest

The authors declare that they have no conflict of interest.

Authors’ information

AS, MD is a family physician in 125. Yil Yahyalar Family Health Center, Ankara, Turkey. AhA, MD is a Professor in Medical Pharmacology Department of Marmara University School of Medicine, Istanbul, Turkey and still a member of “Board of Rational Use of Medicines of Turkish Ministry of Health” since its establishment. VA, MD is a doctorate student in Medical Pharmacology Department of Health Sciences Institute of Marmara University. BM, Pharm. works at Monitoring and Assessment Unit of the Department of Rational Use of Medicines in Turkish Medicines and Medical Devices Agency. MS, Pharm. is the Head of Department of Rational Use of Medicines in Turkish Medicines and Medical Devices Agency. AlA, MD is the Vice President of the Turkish Medicines and Medical Devices Agency in charge of Drug and Pharmacy.

Electronic supplementary material

Online Resource 1

(PDF 79 kb)

Online Resource 2

(PDF 270 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sahin, A., Akici, A., Aydin, V. et al. Variation of antibiotic consumption and its correlated factors in Turkey. Eur J Clin Pharmacol 73, 867–873 (2017). https://doi.org/10.1007/s00228-017-2229-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-017-2229-z

Keywords

Navigation